Vivoryon Therapeutics NV
XETRA:05Y
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vivoryon Therapeutics NV
XETRA:05Y
|
DE |
|
T
|
TX Group AG
LSE:0QO9
|
CH |
|
F
|
Ford Motor Co
XHAM:FMC1
|
US |
|
Infineon Technologies AG
OTC:IFNNF
|
DE |
|
Ameris Bancorp
NASDAQ:ABCB
|
US |
|
H
|
Huntington Ingalls Industries Inc
SWB:HI4
|
US |
|
Microbot Medical Inc
NASDAQ:MBOT
|
US |
|
KT&G Corp
KRX:033780
|
KR |
|
Fomento de Construcciones y Contratas SA
F:FCC0
|
ES |
|
S
|
Sasol Ltd
XBER:SAO
|
ZA |
|
V
|
Vaudoise Assurances Holding SA
SWB:VAHB
|
CH |
|
Wabash National Corp
NYSE:WNC
|
US |
|
N
|
Nordstrom Inc
SWB:NRD
|
US |
|
F
|
Fortinet Inc
SWB:FO8
|
US |
|
A
|
Apollo Global Management Inc
LSE:0A72
|
US |
|
W
|
WW Grainger Inc
DUS:GWW
|
US |
|
A
|
Asics Corp
SWB:ASI1
|
JP |
|
Ventia Services Group Ltd
ASX:VNT
|
AU |
|
B
|
Baker Hughes Co
NASDAQ:BKR
|
US |
|
Home Depot Inc
NYSE:HD
|
US |
|
Unipol Gruppo SpA
MIL:UNI
|
IT |
|
Cardinal Health Inc
NYSE:CAH
|
US |
|
Penske Automotive Group Inc
NYSE:PAG
|
US |
|
Premia Finance SpA Societa di Mediazione Creditizia
MIL:PFI
|
IT |
Dividends
Dividend Yield
Vivoryon Therapeutics NV
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Vivoryon Therapeutics NV
05Y have decreased by 0%.
Payout Ratio
Vivoryon Therapeutics NV
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 05Y is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
05Y Price
Vivoryon Therapeutics NV
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -63% |
| Market Capitalization | 37.6m EUR |
| Shares Outstanding | 22 050 500 |
| Percentage of Shares Shorted |
N/A
|
